School of Medicine


Showing 1-7 of 7 Results

  • John W. Day, MD, PhD

    John W. Day, MD, PhD

    Professor of Neurology, of Pediatrics (Genetics) and, by courtesy, of Pathology

    Current Research and Scholarly InterestsOur Neuromuscular Division coordinates a comprehensive effort to conquer peripheral nerve and muscle disorders, including the muscular dystrophies, motor neuron disorders, neuromuscular junction abnormalities, and peripheral neuropathies. With patients and families foremost in mind, we have had success defining and combating these diseases, with research focused on identifying genetic causes, developing novel treatment, and maximizing patient function by optimizing current management.

  • Jun Ding

    Jun Ding

    Associate Professor of Neurosurgery and of Neurology

    Current Research and Scholarly InterestsNeural circuits of movement control in health and movement disorders

  • Les Dorfman, MD

    Les Dorfman, MD

    Professor of Neurology and Neurological Sciences, Emeritus

    Current Research and Scholarly InterestsClinical electrophysiology of the peripheral and central nervous systems, including nerve conduction velocity; electromyography (EMG); and visual, auditory and somatosensory evoked potentials. Multiple sclerosis (MS) diagnosis and treatment. Neurological education.

  • Dawn Duane

    Dawn Duane

    Clinical Associate Professor, Neurology & Neurological Sciences
    Clinical Associate Professor, Pediatrics - Operations

    Current Research and Scholarly InterestsI am a general pediatric neurologist. My interest is in clinical diagnosis and treatment of common neurologic diseases in pediatric patients and teaching feature doctors, neurologists and pediatric neurologists about pediatric neurology.

  • Shefali Dujari, MD

    Shefali Dujari, MD

    Clinical Assistant Professor, Neurology & Neurological Sciences

    BioDr. Dujari is a neurologist who practices at Stanford Health Care – ValleyCare in Pleasanton. She is also a clinical assistant professor in the Department of Neurology at Stanford University School of Medicine.

    She is dedicated to continuously improving the quality of patient care. She places special emphasis on enhancing patient-doctor communication.

    She has made presentations to Stanford University School of Medicine on the treatment of bacterial meningitis and the management of thunderclap headaches in the emergency department. Posters co-developed by Dr. Dujari on quality improvement and patient safety advances have been presented at the Neurohospitalist Society Meeting and American Academy of Neurology Annual Meeting.

    Dr. Dujari has earned honors from Stanford University School of Medicine, Boston University School of Medicine, and University of California, Davis. She also received the American Academy of Neurology Annual Meeting resident scholarship.

    She is a member of the American Academy of Neurology and Alpha Omega Alpha Medical Honor Society. She is also a member of the Stanford Hospital Neurology Quality Council.

    Dr. Dujari has led teams including the Resident Safety Council of Stanford Hospital, which designs and implements improvements in the patient healthcare experience, with a focus on improving communication about medication side effects. She led the wellness initiative of the Stanford Neurology Wellness and Mentoring Program to reduce resident burnout and increase peer-to-peer mentorship.

    In addition, she co-founded Dance for Health at Boston University School of Medicine, which taught dance classes at assisted living and senior centers to improve motor coordination and create a social outlet for the elderly.

  • Jeffrey Dunn, MD

    Jeffrey Dunn, MD

    Clinical Professor, Neurology & Neurological Sciences

    Current Research and Scholarly InterestsTranslational research in the human application of emerging immunotherapies for neurological disease, focusing on Multiple Sclerosis, CIS, transverse myelitis and Neuromyelitis Optica (NMO). Collaborative research with Stanford and extramural scientific faculty to identify biomarkers of disease activity and treatment response in humans. Clinical trials to assess efficacy of emerging treatments for MS, CIS and NMO.

  • Emmanuel During, MD

    Emmanuel During, MD

    Clinical Associate Professor, Psychiatry and Behavioral Sciences - Stanford Center for Sleep Sciences and Medicine
    Clinical Associate Professor, Neurology & Neurological Sciences

    Current Research and Scholarly InterestsImproving diagnostics and therapeutics in RBD, using home ambulatory devices including wearable actigraphy, dry-EEG, to power clinical trials based on objective outcomes of RBD activity.

    Controlling symptoms of RBD testing drugs rigorously.

    Predicting the course of neurodegeneration using deep phenotyping using clinical and serum biomarkers, measures of autonomic impairment, skin biopsy, microbiome